Efficacy of Ventavis used in real-life setting. (SPHERA)
This is a registry of patients diagnosed with pulmonary arterial hypertension, scheduled for treatment with Ventavis.
Typical clinical measures and quality of life will be prospectively followed in 12 months period.
- Pulmonary arterial hypertension in WHO functional class III or IV - Age 18+ - Patients newly treated with Ventavis or switched from sildenafil
- Retrospective documentation is not allowed
Many Locations, Poland
E-mail: [email protected]
Phone: Not Available
The efficacy of inhaled iloprost in patients treated within the “Pulmonary Arterial Hypertension Therapeutic Programme”.